Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide Mononitrate Plus Amlodipine for Radial Artery Grafts
NCT06730945Phase 4Withdrawn
- Sponsor
- Ruijin Hospital
- Start
- Jun 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of isosorbide mononitrate, amlodipine in Graft failure, sponsored by Ruijin Hospital. Planned start Jun 2025; status: withdrawn.
02
Drugs
isosorbide mononitrateamlodipine
03
Conditions
Graft failure
Beyond the preview
Go deeper on NCT06730945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06730945.